-
New psyllite arthritis (PsA) drug! Johnson and Johnson IL-23 inhibitor Tremfya (Tenoya ®) was approved by the U.S. FDA and is listed in China!
Time of Update: 2020-07-17
July 14, 2020 // Johnson and Johnson (JNJ) Janssen Pharmaceuticals (JNJ) recently announced that the U.S Food and Drug Administration (FDA) has approved Tremfya (Tenoya®, generic name: guselkumab, gus
-
New study: There are large differences in plasma and abilities among the recovered.
Time of Update: 2020-07-17
Springer Nature's international professional academic journal Nature-Medicine, Nature-Structure and Molecular Biology, published online on the 13th on the new study paper on the outbreak of neo-corona
-
Science: Reveals the common molecular characteristics of powerful human antibodies that are powerfully neutralized with SARS-CoV-2.
Time of Update: 2020-07-17
!--:page title,14 (upi) -- --- In a new study, researchers from the Scripps Research Institute in the United States have found common molecular characteristics in humans and in the--- --- of a new cor
-
Nature is a major development! Develop an efficient mitochondrial DNA base editor!
Time of Update: 2020-07-17
!--:page title"--July 14, 2020 /PRNewswire/ -- In a ground-breaking study published recently in Nature, researchers used swords to be ploughed into a bacterial toxin into a genome-editing tool, the fi
-
Nat Immunol: Breakthrough! Uncover the reasons for the failure of CAR-T cell therapy! Because it can not destroy the expression of a small number of tumor antigen cancer cells!
Time of Update: 2020-07-17
11, 2020 // CAR-T Cell Therapy is a revolutionary new cancer-fighting weapon that is genetically modified to be inherited from T-cells isolated from the blood of the patient's body and then infusions
-
JEM: The King of Cancer Research's New Discovery! Blocking cell cholesterol storage may inhibit the progression of pancreatic cancer.
Time of Update: 2020-07-17
July 11, 2020 // In a recent study published in the international journal Journal of Medicine, scientists from cold spring port labs and other institutions have found that interfering with the growth
-
PNAS: Discover switches associated with inflammation caused by overeating may help develop new treatments for metabolic diseases such as obesity.
Time of Update: 2020-07-17
July 11, 2020 // In a recent study published in the international journal PNAS, scientists from Yale University and others identified a particular molecule that plays a key role in the body's inflamma
-
"Turn" visit to Fudan University Zhongshan Hospital Professor Wu Dojiao: single-cell sequencing technology for the field of immune metabolism has brought new opportunities and challenges.
Time of Update: 2020-07-17
after the conference, I had an in-depth interview with Professor Wu Duojiao, the Clinical Medicine Research Institute of Zhongshan Hospital Affiliated to Fudan University, and asked her to introduce the research related to immune metabolism and the application and development of single cell sequencing.
-
A new drug for adhesion dermatitis (AD) ! Leo Pharmaceuticals Anti-IL-13 Monotarokinumab: The first challenger of Nofi Dupixent biopharmaceuticals!
Time of Update: 2020-07-17
11, 2020 // Leo Pharma, a Danish pharmaceutical company, recently announced that the U.S Food and Drug Administration (FDA) has accepted a biological product licensing application (BLA) for tralokinum
-
I can't think of that, do you? Young women have acute abdominal pain, which may be the disease...
Time of Update: 2020-07-17
gastrointestinal tract is the most common site of SLE involving digestive system, accounting for 29% - 65% of SLE patients with abdominal pain.
abdominal enhanced CT examination is helpful for the early diagnosis of gastrointestinal involvement in SLE.
-
A new drug for specific dermatitis (AD) itching! New anti-inflammatory drug: IL-31 receptor A targeted blocking antibody nemolizumab Phase III clinical success!
Time of Update: 2020-07-17
!--webeditor:page title"--Twitterderitis (Photo: salinetherapy.com) July 12, 2020 // Maruho is a Japanese pharmaceutical company focused on the development of new drugs for dermatology , the company a
-
How can new biologic IL-17A inhibitors benefit more patients? Experts say so.
Time of Update: 2020-07-17
Hope more biological agents into the medical insurance, let more patients benefit! Spinal arthritis (SPA) is a kind of chronic inflammatory rheumatism which mainly involves spine, joints, ligaments an
-
CMAJ: New discovery! Pasteurization or can effectively promote SARS-CoV-2 inlconotization in breast milk!
Time of Update: 2020-07-17
July 11, 2020 // In a recent study published in the international journal CMAJ, scientists from the University of Toronto and other institutions found that pasteurized breast milk using commonly used
-
FDA approves Hulio biosimilar (adalimumab-fkjp)
Time of Update: 2020-07-16
The U.S FDA has approved hulio ®, a biological analogue of the Humira ®, the U.S FDA announced today !---- Hulio pre-installed syringes and auto-injectable syringes can treat rheumatoid arthritis, ju
-
FDA approves first typelir-23 monoanti-TREMFYA (guselkumab) for the treatment of psoriasis arthritis
Time of Update: 2020-07-16
!----, The U.S Food and Drug Administration (FDA) has approved its TREMFYA (guselkumab) for the treatment of active psoriasis arthritis (PSA), characterized by joint pain and skin inflammation TREMFY
-
Cell: Heavyweight! Chinese scientists have successfully mapped a comprehensive proteomic map of human lung adenocarcinoma!
Time of Update: 2020-07-16
July 15, 2020 // In a recent study published in the international journal Cell, scientists from the Shanghai Institute of Pharmaceutical Research of the Chinese Academy of Sciences conducted a compreh
-
EbioMedicine breakthrough! Researchers take an important step towards curing AIDS!
Time of Update: 2020-07-16
July 15, 2020 /PRNewswire/ -- Researchers have developed a way to separate HIV from potential hosts, allowing the immune system to see the virus and offering the possibility of killing the virus Part
-
What kind of antibodies are strong against the new coronavirus? "Science" latest research finds key factors
Time of Update: 2020-07-16
The development of an effective vaccine is an extremely urgent task in order to halt the worldwide pandemic of the new coronavirus recovering from the new coronavirus, many researchers have identifie
-
FDA receives BLA for tralokinumab treatment for moderate-to-severe adhesitis
Time of Update: 2020-07-16
!-----specific dermatitis (AD) is a chronic, itchy, inflammatory skin disease that most commonly affects children but also affects many adults Clinical features of -specific dermatitis include dry ski
-
Int J Mol Sci Breakthrough! The study identified possible immune targets in the SARS-CoV-2 genome!
Time of Update: 2020-07-16
July 15, 2020 /PRNewswire/ -- Scientists at the University of Otago, which studies the COVID-19 virus (SARS-2), have identified potential targets in their genomes that could help treat the virus in th
